Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (529)	8/5/2019 6:36:59 PM
From: BulbaMan	Read Replies (1) \| Respond to of 684

Thanks RKRW, but not the kind of deal that I’m looking for. ;~) Amount of RLM cash was limited (under $20 million) and deal has so far turned out poorly for both companies. Meanwhile, if stocks/biotechs continue to plunge, biotechs with significant cash (e.g., > $100 million) will be able to get some promising pipelines cheap. We’ll see if such deals happen. Peace & good health, Bulba